Sama Therapeutics
1 known investors
Find your way into Sama Therapeutics
Sign up to see every warm intro you have to Sama Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sama Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sama Therapeutics develops iMAGiNE, an AI/ML biomarker platform for precision neuropsychiatry that predicts treatment response across psychiatric and neurological disorders. It serves pharmaceutical and clinical trial developers, care providers, and individuals tracking brain health, operating as software-as-a-medical-device in the neurotechnology and digital health space.
Investors · 1
Frequently asked questions
- What does Sama Therapeutics do?
- Sama Therapeutics develops iMAGiNE, an AI/ML biomarker platform for precision neuropsychiatry that predicts treatment response across psychiatric and neurological disorders. It serves pharmaceutical and clinical trial developers, care providers, and individuals tracking brain health, operating as software-as-a-medical-device in the neurotechnology and digital health space.
- Who are Sama Therapeutics's investors?
- Sama Therapeutics's investors include Mystic Ventures.